About 858 Therapeutics
858 Therapeutics is a biotechnology and drug discovery company developing a portfolio of small molecule drugs that act on novel therapeutic targets in oncology, neuroscience, and cardiovascular disease.
858 was founded by a veteran team who together bring a track record of success in pharma and biotech drug discovery. Building from our collective experience in oncology and drug development, 858 scientists are dedicated to the company's mission to discover innovative therapeutics for the treatment of cancers that are resistant to current therapies.
858 is headquartered in the biotech hub of San Diego, CA, and maintains lab operations in San Diego, providing proximity to leading investigators and scientific talent.
